4D Molecular Therapeutics (FDMT) Earnings Date & Reports

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FDMT is expected to report earnings to fall 3.96% to -97 cents per share on August 06

4D Molecular Therapeutics FDMT Stock Earnings Reports

Q2'26

Est.

$-0.97

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.96

Q3'25

Est.

$-1.01

Q2'25

Missed

by $0.25

The last earnings report on May 07 showed earnings per share of -100 cents, missing the estimate of -100 cents. With 61.00K shares outstanding, the current market capitalization sits at 461.86M.

View a ticker or compare two or three

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+19%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

FDMT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement